Yang, Y. Y., Deng, Y. H., Sun, L. H.
, Rejnmark, L., Wang, L., Pietschmann, P., Glüer, CC., A. Khan, A., Minisola, S. & Liu, J. M. (2025).
Hypoparathyroidism: Similarities and differences between Western and Eastern countries.
Osteoporosis International,
36(3), 391-402.
https://doi.org/10.1007/s00198-024-07352-6Yan, X., Wang, Z., Westberg-Rasmussen, S., Tarbier, M., Rathjen, T., Tattikota, S. G., Peck, B. C. E., Kanke, M.
, Oxvig, C., Frystyk, J., Starup-Linde, J., Sethupathy, P., Friedländer, M. R.
, Gregersen, S. & Poy, M. N. (2017).
Differential impact of glucose administered intravenously and orally on circulating miR-375 levels in human subjects.
Journal of Clinical Endocrinology and Metabolism,
102(10), 3749-3755.
https://doi.org/10.1210/jc.2017-01365Yale, J. F., Bodholdt, U., Catarig, A. M., Catrina, S., Clark, A., Ekberg, N. R., Erhan, U., Holmes, P.
, Knudsen, S. T., Liutkus, J., Sathyapalan, T., Schultes, B. & Rudofsky, G. (2022).
Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Pooled analysis of data from four SURE studies by baseline characteristic subgroups.
BMJ Open Diabetes Research & Care,
10(2), Article e002619.
https://doi.org/10.1136/bmjdrc-2021-002619Yakar, S., Liu, J. L., Fernandez, A. M., Wu, Y., Schally, A. V.
, Frystyk, J., Chernausek, S. D., Mejia, W. & Le Roith, D. (2001).
Liver-specific IGF-I gene deletion leads to muscle insulin insensitivity.
Diabetes,
50(5), 1110-1118.
Yakar, S., Rosen, C. J., Beamer, W. G., Ackert-Bicknell, C. L., Wu, Y., Liu, J. L., Ooi, G. T., Setser, J.
, Frystyk, J., Boisclair, Y. R. & LeRoith, D. (2002).
Circulating levels of IGF-1 directly regulate bone growth and density.
J. Clin. Invest.,
110(6), 771-781.
Yakar, S., Rosen, C. J., Bouxsein, M. L., Sun, H., Mejia, W., Kawashima, Y., Wu, Y., Emerton, K., Williams, V., Jepsen, K., Schaffler, M. B., Majeska, R. J., Gavrilova, O., Gutierrez, M., Hwang, D., Pennisi, P.
, Frystyk, J., Boisclair, Y., Pintar, J. ... LeRoith, D. (2009).
Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism.
F A S E B Journal,
23(3), 709-19.
https://doi.org/10.1096/fj.08-118976Xiang, X., Zhao, X., Pan, X., Dong, Z., Yu, J., Li, S., Liang, X., Han, P., Qu, K.
, Jensen, J. B., Farup, J., Wang, F., Petersen, T. S., Bolund, L., Teng, H.
, Lin, L. & Luo, Y. (2021).
Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAs.
Molecular Therapy - Nucleic Acids,
24, 403-415.
https://doi.org/10.1016/j.omtn.2021.03.005
Xiang, X., Corsi, G. I., Anthon, C., Qu, K., Pan, X., Liang, X., Han, P., Dong, Z., Liu, L., Zhong, J., Ma, T., Wang, J., Zhang, X., Jiang, H., Xu, F., Liu, X., Xu, X., Wang, J., Yang, H.
... Luo, Y. (2021).
Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning.
Nature Communications,
12(1), Article 3238.
https://doi.org/10.1038/s41467-021-23576-0
Wong, C. K., McLean, B. A., Baggio, L. L., Koehler, J. A., Hammoud, R.
, Rittig, N., Yabut, J. M., Seeley, R. J., Brown, T. J. & Drucker, D. J. (2024).
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation.
Cell Metabolism,
36(1), 130-143.
https://doi.org/10.1016/j.cmet.2023.11.009